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ABSTRACT 
Objective: Present study is aimed at formulation of Hydrogel containing Poly Lactic Glycolic Acid (PLGA) nanoparticles incorporated with ethanolic 
extract of Crossandra infundibuliformis (EECI) and investigate the efficacy of hydrogel nanoparticles as a carrier of antimicrobial constituents.  
Methods: Poly Lactic Glycolic Acid (PLGA) nanoparticles containing ethanolic extract of Crossandra infundibuliformis (EECI) were synthesized by an 
emulsion-evaporation method and their physicochemical properties were studied. Polymeric PLGA nanoparticles were then incorporated into gel 
matrix, using Hydroxy Propyl Methyl Cellulose (HPMC K4M) as a base. The antibacterial activity of nanoparticulated hydrogel formulations were 
evaluated by agar well diffusion method against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa. 
Results: Nanoparticulate hydrogel formulations exhibited high viscosity, neutral pH with good spreadability which is appropriate for transdermal 
application as well as showed prolonged drug release from optimized formulation up to 24 h. Nanoparticulate hydrogel formulations were effective 
inhibitors of all the micro-organisms with more promising activity against Staphylococcus aureus. 
Conclusion: Nanoparticulate hydrogel formulation can be used as a feasible alternative to conventional formulations of Crossandra 
infundibuliformis extract with advanced permeation characteristics of antimicrobial constituents for transdermal application. 
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INTRODUCTION 
In recent years, encapsulation of antimicrobial drugs in nanoparticle 
systems has emerged as an innovative and promising alternative 
that enhances therapeutic effectiveness and minimizes undesirable 
side effects of the drugs. Many antimicrobial drugs are difficult to 
administer because of their low water-solubility, cytotoxicity to 
healthy tissues, and rapid degradation and clearance in the 
bloodstream. Their antimicrobial activities against intracellular 
microbes are also severely limited by poor membrane transport 
ability. Extensive studies have demonstrated that nanoparticles such 
as liposomes, polymeric nanoparticles, solid lipid nanoparticles, and 
dendrimers are able to overcome these issues and facilitate 
antimicrobial delivery to microbial infection sites [1]. 
Polymeric nanoparticles are made from biodegradable and 
biocompatible polymers, represent an option for controlled drug 
delivery and are promising formulation used for drug delivery 
systems, because they can be targeted whereas hydrogel 
nanoparticles, which are currently being widely explored for the 
delivery of hydrophilic as well as hydrophobic actives, comprise 
particles of polymeric mesh with a high capacity to imbibe water or 
biological fluids due to the presence of hydrophilic groups on their 
surface. They offer unique characteristics of swelling in water, 
instead of being dissolved in the surrounding aqueous medium, due 
to the crosslinks present in the polymeric structure [2]. 
Crossandra infundibuliformis belonging to family Acanthaceae is 
observed to show several medicinal properties and especially, its 
leaf extract was reported to have the antioxidant, antibacterial, 
antifungal, anticandidal and larvicidal activity [3-6]. These activites 
may be due to the presence of phytoconstituents such as 
carbohydrates, flavanoids, alkaloids, steroids, tannins, terpenoids, 
Saponins which was reported in the extracts of Crossandra 
infundibuliformis leaves from the phytochemical analysis [7]. Leaf 
extract was also found to effective topically for wound healing [8]. 
Considering the above facts, present study was done to exploit the 
size and hydrophilic nature of the formulated nanocarriers to 
enhance the antimicrobial effect. 
MATERIALS AND METHODS 
Preparation of plant extract  
Fresh leaves of Crossandra infundibuliformis were collected from 
local area of Bantwal Taluk and authenticated by Prof (Dr) 
Nagalakhamma St. Aloysius College, Mangalore. Plant material was 
washed under running tap water to remove adhering dust, dried 
under shade and powdered. Powdered leaf drug was extracted by 
cold maceration method using 95% ethanol as a solvent for 7 d. 
After the extraction solution was filtered and the filtrate was 
evaporated to dryness and the percentage yield was calculated.  
Calibration of Crossandra infundibuliformis extract by UV-
visible spectrophotometer 
The ethanolic extract was dissolved in small amount of ethanol, 
followed by addition of phosphate buffer of pH 6.8 and then suitably 
diluted. The solutions were scanned for its specific UV-visible range 
of absorbance maxima. Then the absorbance of the different serial 
diluted samples was measured at the λ max, and a standard 
calibration curve was plotted with concentration against 
absorbance. 
Nanoparticle synthesis 
For the synthesis of polymeric nanoparticles, PLGA (50:50) was 
procured from Sigma Aldrich, Bangalore Three nanoparticle 
formulations (N1, N2, N3) with different extract/polymer ratios were 
synthesized by emulsion-solvent evaporation method [9]. During the 
process, the organic phase was prepared by dissolving accurately 
weighed PLGA and plant extract in dimethyl sulphoxide (DMSO) as 
organic solvent. The organic phase was then added dropwise at the 
rate of 1 ml/min into an aqueous phase containing surfactant i. e Poly 
Vinyl Alcohol (PVA-0.5%). The nanoparticles suspension was kept 
under continuous stirring at 300 rpm for 3 h at 30 °C to allow the 
complete evaporation of DMSO, leaving behind the colloidal 
suspension of PLGA nanoparticles containing plant extract in the 
aqueous phase. The colloidal nanosuspension was centrifuged at 
12,000 rpm (Remi, Mumbai, India) for 30 min at 4 °C to get the final 
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nanoparticulate containing pellet as encapsulated plant extract. The 
pellet was washed with deionized water twice to remove the un-
entrapped drug from the surface of nanoparticles. The obtained 
nanoparticles loaded suspensions were stored at 4°C until further use. 
Free nanoparticles were synthesized with the same protocol without 
extract. Formulation ingredients of nanoparticles are given in table 1. 
  
Table 1: Composition of polymeric nanoparticle 
Formulations Drug (mg) Polymer (mg) Surfactant (%) 
N1 25 50 0.5 
N2 25 100 0.5 
N3  25 200 0.5 
 
Characterization of polymeric nanoparticles  
Surface morphology 
Scanning electron microscopy SEM (JEOL, JSM 50A, Tokyo, Japan) 
was performed to evaluate the shape and the surface morphology of 
nanoparticles. Transmission Electron Microscopy (TEM) was also 
used to evaluate nanoparticle morphology.  
Particle size analysis, polydispersity index, and zeta potential 
measurements 
Average particle size (z-average) and Polydispersity index (PDI) of 
the developed nanoparticles were determined by laser dynamic light 
scattering using Malvern Zetasizer (Nano ZS, Malvern Instruments, 
UK). The PDI value indicates the particle size distribution of 
nanoparticles in a given sample.  
Zeta potential indicates the surface charge on the particles and was 
measured to determine the stability of nanoparticles in the 
suspension. Zeta potential data of nanoparticles loaded with extract 
was collected through electrophoretic light scattering using Malvern 
Zetasizer (Nano ZS, Malvern Instruments, UK) [11]. 
Entrapment efficiency of the polymeric herbal nanoparticle 
The nanoparticle suspension formulated with the extract and 
polymer was ultra-centrifuged at 18,000 rpm for 30 min in a cooling 
centrifuge apparatus and then the supernatant solution was diluted 
suitably to measure the absorbance, from which the concentration of 
drug in the supernatant was calculated using the standard 
calibration data [12]. The entrapment efficiency of the extract in the 
polymeric nanoparticles was calculated using the formula, 
 
Based on the results of particle size analysis, PDI and entrapment 
efficiency, an optimised formulation of nanoparticles was chosen 
and it was subjected for the formulation of nanoparticles 
Formulation of nanoparticulate hydrogel  
The optimized polymer nanoparticle (N2) was incorporated in the 
hydrogel matrix. HPMC K4M was selected as gel matrix base. HPMC 
K4M was obtained from Yarrow Chem products, Mumbai. Various 
ingredients used in the formulations are shown in table 2. Required 
quantity of gelling agent was weighed and dispersed in a small 
quantity of distilled water to form a homogeneous dispersion. 
Prepared nanoparticle formulation was added to the above solution 
to obtain hydrogel formulation HN1, HN2 and HN3. Other excipients 
were also added with stirring. The pH of this gel preparation was 
maintained 6.5±05 by using Triethanolamine and stored in well 
closed. 
 
Table 2: Composition of hydrogel nanoparticles 
Ingredients HN1 HN2 HN3 
N1 10 mg 10 mg 10 mg 
Carbopol 934 500 mg 500 mg 250 mg 
HPMC K4M  250 mg 500 mg 500 mg 
Glycerine 2 ml 2 ml 2 ml 
Sodium benzoate 100 mg 100 mg 100 
Triethanolamine q. s q. s q. s 
Distilled water q. s q. s q. s 
 
Antimicrobial screening of extracts 
Ethanolic extract of Crossandra infundibuliformis was evaluated for 
their antimicrobial activities against Staphylococcus aureus, Bacillus 
subtilis, Escherichia coli and Pseudomonas aeruginosa. The 
antimicrobial activity was determined by the agar well diffusion 
method using Muller Hinton agar media. Each petri dish containing 
Muller-Hinton agar medium was inoculated with one bacterial culture 
by spreading the suspension of the organism with a sterile glass rod 
with a bended tip. Wells were made on the agar surface with 6 mm 
cork borer. The first cup was filled with Ciprofloxacin, the second was 
filled with dimethyl formamide and other is filled with extracts (50 
mg/ml) using the sterile syringe. The plates were incubated at 37±2 °C 
for 24 h. The plates were observed for the zone formation around the 
wells. The zone of inhibition was calculated by measuring the diameter 
of the inhibition zone around the well (in mm) including the well 
diameter [13]. The readings were taken in three different fixed 
directions in all 3 replicates and the average values were tabulated. 
In vitro drug release study 
Release study of hydrogel nanoparticles HGN1, HGN2, HGN3 was 
conducted to determine the release of the extract constituents from 
the formulations by dissolution method. In vitro release of the drug 
across the dialysis bag (12 Kda, Hi Media) soaked in deionized water 
for 12 h before use was performed by using diffusion cell (containing 
1 ml of sample) and 80 ml of phosphate buffer pH 6.8 as the 
dissolution medium (n=6). The dissolution medium was maintained 
at 37±0.5 °C and the medium was stirred at 100 rpm with the help of 
small teflon coated magnetic bead. Aliquots of the medium were 
withdrawn at a suitable time interval and were replaced with the 
same volume of fresh medium to maintain the sink condition. These 
samples were filtered through 0.45 μm membrane filter and the 
collected samples were analyzed using UV-visible 
spectrophotometer at the λmax of 203 nm. The concentration of 
extract constituents was calculated by comparing the concentration 
to the standard calibration curve. 
Characterization of hydrogel formulations  
Determination of drug content  
The amount of drug contained in the prepared hydrogel was 
determined by dissolving 100 mg of prepared hydrogel in acetone and 
diluted using phosphate buffer of pH 6.8. This mixture was analysed 
UV spectrophotometer at 203 nm against phosphate buffer as blank.  
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pH determination  
The pH of the formulation was determined at ambient temperature 
with digital pH meter (digital pH meter, 335, systronics, Noroda, 
Ahmedabad).14 since the formulation was a topical formulation to 
be applied to the skin, therefore pH measurement was essential to 
ensure non-irritating nature of the formulation [13].  
Determination of spreadability  
The spreadability of prepared hydrogel formulation was determined 
48 h after preparation by measuring the spreading diameter of 
formulation between the two glass plates after 1 min. A weight of 
500 mg of hydrogel was placed within a circle of diameter 1 cm 
premarked on a glass plate over which a second glass plate was 
placed. The increase in diameter as a consequence of weights added 
leading to the spreading of gel was noted [14]. 
Measurement of viscosity  
The viscosity of the prepared formulations was determined at 
different angular velocities at 32.0±0.1 °C using spindle number 4 
(Brookfield DV-II+Pro viscometer) [15]. 
RESULTS  
Calibration of the crude extract 
Ethanolic extract of Crossandra infundibuliformis were greenish in 
colour and percentage yield was found to be 14% respectively. The 
crude ethanolic extract of Crossandra infundibuliformis was 
dissolved in the little amount of ethanol and diluted with phosphate 
buffer of pH 6.8 and scanned in a UV-spectrophotometer have shown 
the maximum absorbance wavelength at 203 nm. The serially 
diluted samples of the extract exhibited the absorbance value in the 
linearity range and their regression was found to be 0.998 (fig. 1). 
 
 
Fig. 1: Calibration curve of ethanolic extract of Crossandra 
infundibuliformis 
 
Characterization of polymeric nanoparticles  
The results of entrapment, size and charge of the nanoparticles are 
shown in table 3, where N1, N2, N3 are nanoparticles of Crossandra 
infundibuliformis ethanolic extract with different concentration of 
PLGA respectively. 
 
Table 3: Physicochemical characterization of nanoparticles loaded with extract of crossandra infundibuliformis 
Formulations Particle size PDI Zeta Potential Entrapment Efficiency 
N1 143.9 0.235 -2.08 68.5 
N2 283.8 0.267 -3.24 65.3 
N3  321.8 0.299 -3.58 62.9 
All values are expressed as mean±SD (n=3); N1: nanoparticles with 50 mg PLGA, N2: nanoparticles with 100 mg of PLGA, N3: nanoparticles with 
200 mg PLGA 
 
Scanning electron microscopy (SEM) 
Shape and surface morphology of the nanoparticles in optimized 
formulation N1 was studied using SEM. The SEM study reveals that 
polymeric nanoparticles were spherical in shape with an average 
particle size around 143.9 nm as shown in fig. 2. 
 
 
Fig. 2: SEM image of optimized PLGA nanoparticle formulation (N1) 
 
Transmission electron microscopy (TEM) 
The transmission electron microscope revealed a positive image in 
which nanoparticles appeared dark with bright surroundings as 
shown in fig. 3. The particle size of sample was less than 1000 nm 
 
Fig. 3: TEM image of optimized PLGA nanoparticle formulation (N1) 
 
Based on results of particle size and entrapment efficiency, 
nanoparticle formulation N1 containing Crossandra infundibuliformis 
ethanolic extract with 50 mg of PLGA polymer was selected as 
optimised formulation as it has nanosize range (<200 nm) particles 
with low PDI and sufficient entrapment efficiency.  
Formulation and characterisation of nanoparticulate hydrogel 
formulation 
Hydrogel formulations HN1, HN2, HG3 were prepared by 
incorporating optimised polymeric nanoparticle formulation (N1) to 
varying ratios of HPMC K4M: carbopol 934 hydrogel forming matrix 
1:2, 1:1 and 2:1 respectively. Prepared hydrogel were subjected for 
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determination of pH, spreadability, viscosity and drug content and 
results of which is shown in table 4.  
The drug content of nanoparticulate hydrogel formulation was in the 
range of 96.6±0.38% to 97.8±0.23%. The pH values of different 
nanoparticulate hydrogel formulations were found to be in a range 
of 6.6–6.8 (nearly neutral). The spreadability of the all formulations 
exhibited slip and drag phenomenon with higher diameters. 
Viscosity of hydrogel formulation decrease as the ratio of carbopol: 
HPMC decreases. 
 
Table 4: Characterization of hydrogel nanoparticles 
Formulations Drug content  pH  Spreadability (cm)  Viscosity (m. PaS)  
HN1 97.8±0.23  6.7±0.2 6.0±0.32 4312±0.21 
HN2 96.4±0.21 6.6±0.3 5.5±0.22 4325±0.18 
HN3  96.6±0.38 6.7±0.1 5.8±0.42  4350±0.16 
 All the values are expressed as mean±SD (n= 3), HN1, HN2, HG3: Hydrogel formulations with HPMC K4M: carbopol 934 in the ratio 1:2, 1:1 and 2:1. 
 
Release studies from nanoparticulate hydrogel formulation 
Drug release from hydrogel formulation HGN3 was found to be the 
highest of 89.01% whereas it was found to decrease to 75.42% and 
44.67% respectively from formulation HGN2 and HGN1 at the end of 
24h.  
The drug release of formulation HGN1 was found to be 44.67 % 
due to the presence of large concentration of carbopol 934, on 
the other hand, formulation HGN2 and HGN3 shown an increased 
release of 75.42% and 89.01% respectively. On the basis of drug 
release study, formulation HGN3 was found to be optimized 
prepared. 
Antibacterial activity 
Antibacterial activity was investigated against four bacterial strains 
i.e S. aureus, B. subtilis, E. coli and P. aeruginosa and among these S. 
aurei was most susceptible organism with inhibition zones ranging 
from 13-27 mm (table 5). 
 
 
Fig. 4: In vitro drug release profile of nanoparticulate hydrogel loaded with extract of Crossandra infundibuliformis, HN1,HN2, HN3: 
Hydrogel formulations with HPMC K4M: carbopol 934 in the ratio 1:2, 1:1 and 2:1 
 
Table 5: Zone of inhibition against bacterial strains 
Samples Zone of Inhibition (mm) 
S. aureus B. subtilis E. coli  P. aeruginosa 
EECI  28±0.48 12±0.31 13±0.33  16±0.21 
PLGA nanoparticles(N1) 27±0.41 12±0.21 12±0.24  16±0.24 
Hydrogel(HN1)  27±0.51 11±0.23 12±0.31 16±0.23 
Ciprofloxacin(Standard)  29±0.21 22±0.32 17±0.26  19±0.27 
All the values are expressed as mean±SD (n= 3). 
 
DISCUSSION 
Hydrogels comprise thermodynamically balanced ‘‘solid-like 
solution’’ of polymer and water where equilibrium exists between 
the swelling of the hydrophilic polymer strands and the elastic 
forces of tie-points or junctions of the polymer network [16]. 
Hydrogel nanoparticles offer the combined advantages of both, the 
hydrogels and the nanoparticulate drug delivery systems which 
include hydrophilicity, flexibility, versatility, high water absorptivity, 
and biocompatibility along with the prolonged circulation time and 
active/passive targeting ability of the nanoparticles [17]. The 
present investigation attempted the exploitation of these 
pharmaceutical advantages of the hydrogel nanoparticles to enable 
an enhanced absorption by the virtue of the hydrophilic surface of 
the carrier system. 
In this study, initially Crossandra infundibuliformis extract was 
loaded into PLGA polymer which is biodegradable, biocompatible 
and its sub-products of degradation are non-toxic in superficial 
tissues. Prepared PLGA nanoparticles loaded with Crossandra 
infundibuliformis extract were spherical in shape, are of highly 
homogenous formulations with nanosize range and had better 
entrapment efficiency which was indicated by the SEM/TEM, 
particle size analysis and drug entrapment efficiency value. The low 
PDI values indicated that nanoparticles size was uniform within each 
formulation and found to be stable which was indicated by the zeta 
potential value. The stability of these nanoparticles could be related 
to the fact that NPs with high zeta potential (in modulus) produces 
repulsion among the NPs avoiding NP aggregation. Due to good 
physicochemical properties and capacity to encapsulate drugs, 
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prepared polymeric NP was used as nanocarrier for the phyto-
constituents in the extract of Crossandra infundibuliformis.  
Prepared nanoparticles were incorporated into a hydrogel which 
acts as a carrier for transdermal delivery of phytoconstituents in the 
extract due to its high solubilizing ability and permeation enhancing 
properties. The hydrogel formulations were subjected to drug 
content determination which showed that drug loss during 
formulation occurred within the limits. The pH was near to pH of the 
skin which revealed non-irritating nature of the formulation. The 
spreadability of the all formulations exhibited slip and drag 
phenomenon with higher diameters. 
Hydrogels are appealing for numerous biomedical applications 
because of the material’s ability to serve as a reservoir that releases 
its contents along a predetermined timeframe. The hydrogel 
nanoparticle formulations showed the release of phytoconstituents 
in the sustained manner from hydrogel, due to the presence of the 
sustained release polymer carbopol and HPMC. As the concentration 
of HPMC increased the drug release was found to increase due to its 
hydrophilic nature. On the basis of drug release study, formulation 
HGN3 was found to be optimized formulation. The hydrogels 
showed good antibacterial activity against S. aureus when compared 
with other micro-organisms. 
CONCLUSION 
Hydrogel formulation containing PLGA nanoparticles loaded with 
Crossandra infundibuliformis was successfully formulated and 
showed the sustained release of active constituents with enhanced 
permeation, spreadability which makes it good carrier for 
transdermal delivery of antimicrobial constituents in the extract. 
Hydrogel nanoparticles of Crossandra infundibuliformis in an 
aqueous gel base can be used as an appropriate formulation for the 
antimicrobial activity. 
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